Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2002
05/08/2002EP0839052B1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases
05/08/2002EP0807110B1 Enterokinetic benzamide
05/08/2002EP0804464B1 Aromatic heterocyclic derivatives as enzyme inhibitors
05/08/2002EP0790994B1 Heterocycle substituted propenoic acid derivatives as nmda antagonists
05/08/2002EP0773780B1 Controlled release aqueous emulsion
05/08/2002EP0748316B1 Pyrimidine acyclonucleoside derivatives
05/08/2002EP0737197B1 Amino alkanoic esters of rapamycin
05/08/2002EP0735882B1 Combination contraceptive containing progesterone antagonists and a progestogen
05/08/2002EP0726766B1 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
05/08/2002EP0723545B1 Quinolizinone type compounds
05/08/2002EP0620828B1 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
05/08/2002DE10152369A1 Stable, propellant-free inhalable liquid medicament for treating asthma or chronic obstructive pulmonary disease, containing tiotropium salt and antiallergic agent, antihistamine, steroid or leukotriene antagonist
05/08/2002DE10054482A1 Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them
05/08/2002DE10054481A1 Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them
05/08/2002DE10054341A1 Flavone, flavanone and flavonoid compounds are used as active agents in production of cosmetic or dermatological formulations for prophylaxis and repair of damage to skin DNA
05/08/2002DE10054278A1 Verwendung von Stimulatoren der löslichen Guanylatcyclase zur Behandlung von Osteoporose Use of stimulators of soluble guanylate cyclase for the treatment of osteoporosis
05/08/2002DE10053866A1 Biocompatible liquid formulation, containing a mixture of biopolymers, useful as a lubricant in human and veterinary medicine
05/08/2002DE10053813A1 Neue Verwendung von Sulfonamiden New use of sulfonamides
05/08/2002DE10053799A1 Tetrahydroisoquinoline N-phenylsulfonamide derivatives, useful for treating central nervous system disorders e.g. Alzheimer's disease, dementia are 5-HT6 receptor antagonists
05/08/2002DE10053796A1 Aminonaphthalene N-phenylsulfonamide derivatives, useful for treating central nervous system disorders, e.g. Alzheimer's disease, dementia, Parkinson's disease, are 5-HT6 receptor antagonists
05/08/2002DE10053794A1 Amino- or amido-benzene N-phenylsulfonamide derivatives, useful for treating central nervous system disorders e.g. Alzheimer's disease, dementia, depression, are 5-HT6 receptor antagonists
05/08/2002DE10053496A1 Zusammensetzungen enthaltend Flavonoide und Phloridzin oder Phloretin Compositions containing flavonoids and phloretin or phloridzin
05/08/2002DE10053155A1 Treatment of psoriasis comprises administration of a multivitamin preparation containing vitamins B1, B2, B6, B12, C and E, nicotinamide, dexpanthenol, biotin and folic acid
05/08/2002CN1348500A Novel method for preparing synthesis intermediates
05/08/2002CN1348498A Novel Nucleic acid transferring agents, compsoitions containing them and uses
05/08/2002CN1348483A Stable, aqueous dispersions and stable, water-dispersible dry powders of xanthophylls, and production and use of the same
05/08/2002CN1348463A Immunological herpes simplex virus antigens and methods for use thereof
05/08/2002CN1348461A 17 beta-acyl-17 alpha-propynyl-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
05/08/2002CN1348460A Acetal Benzylmaltosides as inhibitors of smooth muscle cell proliferation
05/08/2002CN1348455A Pyrazolobenzodiazepines as CDK2 inhibitors
05/08/2002CN1348454A Tetracyclic azepinoindole compounds as 5-HT receptor ligands
05/08/2002CN1348453A Derivatives of pyrimido [6.1-a] isoquinolin-4-one
05/08/2002CN1348452A Derivatives of pyrimido [6,1-a] isoquinolin -4-one
05/08/2002CN1348451A Azaindole derivatives for the treatment of depression
05/08/2002CN1348449A Heteroaryl diazacycloalkanes, their preparation and use
05/08/2002CN1348447A 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors
05/08/2002CN1348446A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
05/08/2002CN1348444A 丝氨酸蛋白酶抑制剂 Serine protease inhibitors
05/08/2002CN1348443A N-substituted-N'-substituted urea derivative and medicinal compositions containing the same
05/08/2002CN1348442A Novel sulfonamide compounds and uses thereof
05/08/2002CN1348439A New compounds, their preparation and use
05/08/2002CN1348436A Novel ligands of nuclear receptors PPAR's
05/08/2002CN1348386A Prucalopride oral solution
05/08/2002CN1348385A Preventives/remedies/progression inhibitors for simplex retinopathy or preproliferating retinopathy
05/08/2002CN1348384A An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport
05/08/2002CN1348382A Methods for administration of antibiotics
05/08/2002CN1348378A Method of promoting cervical and vaginal secretions
05/08/2002CN1348377A Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic
05/08/2002CN1348375A Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
05/08/2002CN1348374A Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4-metabolic pathway, and inhibitors of lipid metabolism
05/08/2002CN1348373A Use of 17-ketosteroids for the treatment of malaria and Trypanosomiasis
05/08/2002CN1348372A 药物用途 Drug use
05/08/2002CN1348371A Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
05/08/2002CN1348370A Cyclic protein tyrosine kinase inhibitors
05/08/2002CN1348369A Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
05/08/2002CN1348368A ADP-ribosylation inhibitors and remedies for endotoxin bacterial enteric infection containing proanthocyanidin as the active ingredient
05/08/2002CN1348367A Percutaneous absorption preparations containing oxybutynin
05/08/2002CN1348366A Transdermal therapeutic system with a highly effective neuroleptic agent
05/08/2002CN1348363A Novel pharmaceutical salt form
05/08/2002CN1348362A Magnetically responsive composition
05/08/2002CN1348360A Preparation of aqueous clear solution dosage forms with bile acids
05/08/2002CN1348359A Composition for medicated chewing gums process for manufacturing the same and tablets so obtained
05/08/2002CN1348358A Utilization of an extract of a plant of the cecropia genus
05/08/2002CN1348356A Cosmetic and/or pharmaceutical preparations
05/08/2002CN1348334A Dietary compositions and methods
05/08/2002CN1348008A Production process of compound L-amino acid calcium
05/08/2002CN1347884A Vinyl-pyrrolidone cynnematin with alkali subtituent
05/08/2002CN1347883A Vinyl-pyrrolidone cynnematin with alkali subtituent
05/08/2002CN1347882A Vinyl-pyrrolidone cynnematin with alkali subtituent
05/08/2002CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor
05/08/2002CN1347875A Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound
05/08/2002CN1347874A Application of small dosage of aminoguanidine in anti-senility and preventing and treating senile diseases
05/08/2002CN1347865A Antineoplastic compound and its prepn and pharmaceutical use
05/08/2002CN1347734A Method for treating thrombosis diseases
05/08/2002CN1347720A Hair moistening liquid with functions of nourishing hair, restoring hair, stopping baldness and eliminating scurf
05/08/2002CN1347699A Use of stilbene glycoside in treating dementia
05/08/2002CN1347698A Use of stilbene glycoside in preparing medicine for ischemic cerebrovascular diseases
05/08/2002CN1347697A Prepn. of cyclic nucleotide nutrient liquid
05/08/2002CN1347696A Prepn of composite nucleic acid nutrient liquid
05/08/2002CN1347695A Nucleotide analogue composition
05/08/2002CN1347694A Medicine prepn containing matrine or epimatrine and its application in analgesic medicines
05/08/2002CN1347693A Noval compound, its synthetizing process and therapeutic use
05/08/2002CN1084333C Novel artemisine compounds their producing process and pharmaceutical composition containing them
05/08/2002CN1084332C Active oxygen scavengers containing pterin derivatives
05/08/2002CN1084329C Benzyl piepridine derivative
05/08/2002CN1084209C High polymer antineoplastic guide medicine and preparation thereof
05/08/2002CN1084193C Medicine for lowering blood-sugar and nourishing heart and preparing method
05/08/2002CN1084191C Basin bath medicated liquor for curing tinea pedis, sweaty feet and smelly feet
05/08/2002CN1084190C Dermatologic external therapeutic agent composition containing prostacyclin as active ingredient
05/08/2002CN1084189C Use of 9-deoxy prostaglandin derivatives to treat glaucoma
05/08/2002CN1084188C Preparation of ciprofloxacin pharmaceutical formulation composition
05/08/2002CN1084187C Method for preparing anti-cancer medicine using beta-element as main effective ingredient, and its composition
05/08/2002CN1084186C Liposome composition containing selegilin
05/07/2002US6384281 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors
05/07/2002US6384261 Treating endothelin-mediated disorders; inhibitory binding of endothilin peptides to eta and/or etb receptors; elucidating the physiological and pathophysiological roles and isolating endothelin receptors; antagonists
05/07/2002US6384259 Heat resistant, sterile dosage suitable for reconstitution with a vehicle into an injectible, particle-free product for parenteral administration
05/07/2002US6384252 Fatty acids or derivatives; mammalian mammary glands secretion; stress, anxiety and aggression reduction
05/07/2002US6384236 N-(aroyl)glycine hydroxamic acid derivatives and related compounds
05/07/2002US6384230 2,6-dimethyl-5-((4-ethoxyphenyl)-methoxy)-7-(2-methylthiazol-4-yl)hepta -2,6-dienoic acid ethyl ester from malic acid, wittig reaction with 2-methyl-4-thiazolylmethyl triphenyl phosphonium bromide; intermediates for epothilone a or b
05/07/2002US6384225 Intermediates in the preparation of substituted chroman derivatives